Pfizer and BioNTech expect to produce four billion doses of their COVID-19 vaccine in 2022: regardless of whether the current vaccine or a new Omicron specific vaccine is needed.
Lab data show Valneva vaccine effective against Omicron
COVID-19
New year, new ADC deal: Abzena teams up with BiVictriX, Iksuda taps LegoChem again, Genmab secures access to Dutch tech
Antibody-Drug Conjugates
Ori Biotech raises over $100m, funds to support launch of CGT manufacturing platform
Cell & Gene Therapies
Using mice models to gain insight into immune response to SARS-CoV-2
COVID-19
